European Commission Approves ORSERDU® for ER+ Breast Cancer with ESR1 Mutation

Each year in Europe more than 550,000 patients are diagnosed with breast cancer, of whom 70% have estrogen receptor (ER)-positive disease¹; more tha...

September 14, 2023 | Thursday | News
Abbott Broadens Access to Cutting-Edge Biosimilars in Key Emerging Markets

Abbott to commercialize several biosimilar molecules in key emerging markets in Latin America, Southeast Asia, the Middle East and Africa Spain-based gl...

September 21, 2023 | Thursday | News
Natera Expands I-SPY 2 Collaboration for Signatera™ in Breast Cancer Neoadjuvant Study

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing,  announced a new study as part of the I-SPY 2 trial, sponsored and operated by ...

September 15, 2023 | Friday | News
Eurofins Genomics Adopts Olink® Tech for Precision Medicine Advancement

Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced the collaboration with Eurofins Genomics to bolster its offerings in the fields...

September 13, 2023 | Wednesday | News
Thermo Fisher's Next-Gen Gibco™ CTS™ Dynabeads™ Advance Cell Therapy Manufacturing

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the Gibco CTS Detachable Dynabeads (CTS Detachable Dynabeads)*, its nex...

September 08, 2023 | Friday | News
Cell BioEngines Licenses Patent for Oncology Cell Transplantation

Cell BioEngines, Inc. is strengthening its Intellectual Property portfolio with a patent licensed from the Icahn School of Medicine at Mount Sinai, in New ...

September 08, 2023 | Friday | News
Otsuka collaborates with ShapeTX to develop novel AAV gene therapies for ocular diseases

The companies will collaborate to apply ShapeTX’s AAVid™ capsid discovery platform and transgene engineering technology along with Otsuka&...

September 08, 2023 | Friday | News
Bristol Myers Squibb Signs $50M Deal to Address Immune-Mediated Diseases in Asia

US-based startup Zenas BioPharma has entered into a license and collaboration agreement with Bristol Myers Squibb Company to develop and commercialise ob...

September 07, 2023 | Thursday | News
Exosomes functionally deliver siRNAs in vivo to repress tumor growth

Over the past few years, exosomes have gained significant attentions as a promising drug delivery vehicle in both academic and biomedical industry circles....

September 06, 2023 | Wednesday | News
Novozymes and Bactolife Partner to Cut Weaner Pig Antibiotic Use

Novozymes and the Danish industrial biotech company, Bactolife, have signed a joint development and commercialization agreement to finish development and l...

September 05, 2023 | Tuesday | News
Twist Bioscience and Ono Pharmaceutical Collaborate on Autoimmune Antibodies

“Ono has a strong and proven track record in developing antibody candidates in areas of need, including the development of the anti-PD-1 antibody Opd...

September 01, 2023 | Friday | News
23andMe Granted New FDA Clearance to Report Additional BRCA Variants

510(k) clearance will allow 23andMe to report an additional 41 genetic variants in the BRCA1 and BRCA2 genes that increase risk for breast, ovarian, prosta...

September 01, 2023 | Friday | News
IMUNON Collaborates for Preclinical Lassa Virus Vaccine Study

IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage biotechnology company, announces it has entered into a Cooperative Research and Development Agreement (CRADA)...

August 25, 2023 | Friday | News
CVS Health Launches Cordavis

New business will bring high quality biosimilar products to market with goal of reducing drug spend and ensuring access to affordable medications Cordavis...

August 24, 2023 | Thursday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2023 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in